Inhibitors of checkpoint kinases

Details for Australian Patent Application No. 2006258101 (hide)

Owner Merck & Co., Inc.

Inventors Kreatsoulas, Constantine; Fraley, Mark E.; Dudkin, Vadim Y.; Hoffman, Jacob M.; Arrington, Kenneth L.; Wang, Cheng

Agent Spruson & Ferguson

Pub. Number AU-A-2006258101

PCT Pub. Number WO2006/135604

Priority 60/688,991 09.06.05 US

Filing date 5 June 2006

Wipo publication date 21 December 2006

International Classifications

A61K 31/663 (2006.01)

Event Publications

3 January 2008 PCT application entered the National Phase

  PCT publication WO2006/135604 Priority application(s): WO2006/135604

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

12 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006258102-Formulation of a thienopyridine platelet aggregation inhibitor

2006258099-Herpes virus-based compositions and methods of use in the prenatal and perinatal periods